Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
ONC
ONC News & Events
-
Add to Watchlist
Trade ONC
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
ONC News
BeiGene to Announce Q1 Earnings on April 15
5d ago
seekingalpha
BeOne Medicines Receives Conditional Approval for Lung Cancer Treatment in China
Apr 10 2026
seekingalpha
BEONE MEDICINES: TRUIST SECURITIES LOWERS TARGET PRICE TO $411, DOWN FROM $412
Apr 08 2026
moomoo
BeOne Medicine's BGB-B2033 Receives FDA Orphan Drug Designation
Mar 23 2026
seekingalpha
BeOne Medicines AG Raises 2026 Revenue Guidance Amid Strong Q4 Results
Mar 01 2026
Yahoo Finance
BeiGene to Announce Q4 Earnings on February 26
Feb 25 2026
seekingalpha
Three Growth Stocks to Buy and Hold Long-Term
Feb 21 2026
Fool
HHLR Advisors Fully Exits Baidu Position
Feb 20 2026
Fool
Show More News
ONC Events
03/23 12:00
BeOne Medicinces' Hepatocellular Carcinoma Treatment Granted Orphan Designation by FDA
BeOne Medicinces' treatment of hepatocellular carcinoma was granted orphan designation by the FDA, according to a post to the agency's website.
Show More Events
ONC Monitor News
BeOne Medicines AG Raises 2026 Revenue Guidance Amid Strong Q4 Results
Mar 03 2026
BeOne Medicines sees growth potential amid strong sales of Brukinsa
Feb 26 2026
BeOne Medicines sees strong sales growth amid upcoming Phase 3 results
Feb 25 2026
BeOne Medicines AG reaches 20-day high amid market volatility
Jan 13 2026
BeOne Medicines AG Reports Significant Trial Results
Jan 09 2026
BeOne Medicines AG declines as market weakens
Dec 16 2025
BeOne Medicines AG declines as stock hits 20-day low
Dec 15 2025
BeOne Medicines AG Hits 5-Day Low Amid Market Weakness
Dec 05 2025
Show More Monitor News
ONC Earnings Analysis
No Data
People Also Watch
